Correction to: Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
Crossref DOI link: https://doi.org/10.1007/s40744-020-00241-4
Published Online: 2020-10-08
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shimizu, Hirohito
Kobayashi, Hisanori
Kanbori, Masayoshi
Ishii, Yutaka
Text and Data Mining valid from 2020-10-08
Version of Record valid from 2020-10-08
Article History
First Online: 8 October 2020